It's a week of extremes across the Nordic tech landscape. On one end: Swedish AI legaltech Legora just tripled its valuation to $5.55 billion with a $550 million Series D, cementing Stockholm's reputation as Europe's most prolific AI factory. On the other: Denmark's proposed wealth tax on illiquid shares has founders and VCs openly discussing relocation, with two of the country's most prominent corporate leaders threatening to leave.

Beyond the headline stories, the region's healthcare sector had a strong showing. Danish healthtech Hemi Health secured EUR 4 million to bring structured migraine care to new markets. Copenhagen's Radiobotics announced a merger with Swiss Medimaps Group to build the first complete AI-powered musculoskeletal imaging platform. And the Novo Nordisk Foundation's BioInnovation Institute backed five new deeptech spinouts with EUR 1.3 million in follow-on funding. The Nordic startup scene isn't just producing big rounds. It's producing the kind of infrastructure, both corporate and institutional, that sustains ecosystems over decades.

This week also puts a spotlight on Denmark's growing tension between its ambitions as a startup hub and the political pressures of a welfare state grappling with inequality. The wealth tax debate isn't just a local policy question. It's a test case for whether Nordic countries can maintain their founder-friendly reputations while addressing legitimate concerns about wealth concentration. The answer will matter far beyond Copenhagen.

Legora raises $550M Series D at $5.55B valuation

Stockholm-born Legora has pulled off one of the fastest fundraising trajectories in European tech history. The AI legaltech company tripled its valuation in five months, raising $550 million in a round led by Accel. Benchmark, Bessemer Venture Partners, General Catalyst, ICONIQ, Redpoint, Y Combinator, and a roster of new backers including Bain Capital, Menlo Ventures, and Salesforce Ventures all participated. The company now serves 800 law firms across 50 markets, counts White & Case, Linklaters, and Deloitte among its customers, and is opening offices in Houston and Chicago. Total raised since 2023: $816 million. The team has grown from 40 to 400 in the past year.

CEO Max Junestrand, a former professional gamer turned engineer, has built a company that makes the legal industry's traditional resistance to technology look like a myth. Legora's platform handles document review, legal research, contract drafting, and due diligence, and its agentic workflows layer can automate multi-step processes like M&A sequences overnight. Law firms aren't experimenting anymore. They're embedding.

Hemi Health closes EUR 4M seed for migraine and concussion care

Danish female-led healthtech Hemi Health has raised EUR 4 million in seed funding, led by EIFO and Swiss Health Ventures, with continued backing from Sondo Capital, Alliance Venture Capital, and Crowberry Capital. The company blends physical clinics in Denmark with a proprietary AI-powered digital platform to deliver structured care for migraine, concussion, and whiplash. Co-founder Anna Lofqvist, who lives with migraine herself, built Hemi to replace the fragmented treatment journeys that patients with complex neurological conditions typically endure. The new capital funds expansion into the Netherlands as the company's first international market. Over one billion people globally live with migraine. The care pathway for most of them is, to put it gently, a mess.

Radiobotics and Medimaps merge for end-to-end MSK AI imaging

Copenhagen-based Radiobotics, known for its RBfracture AI platform, is merging with Swiss Medimaps Group to create what the companies describe as the first end-to-end musculoskeletal AI ecosystem. Radiobotics brings automated fracture detection from X-rays. Medimaps brings bone microarchitecture analysis and long-term fracture risk prediction through its TBS Osteo and TBS Reveal tools. The combined entity will serve hospitals, clinics, and imaging centers across 90 markets, including the United States. The deal is pending Danish FDI approval, and financial terms weren't disclosed.

The strategic logic is straightforward: right now, detecting fractures and predicting bone health live in different departments, on different machines, read by different specialists. This merger collapses that silo into a single platform where every X-ray becomes both a diagnostic and a preventive tool. Radiobotics CEO Peter Ulvskjold joins the Medimaps Group Executive Committee, and combined leadership stays in place on both sides.

For the broader medtech AI market, this is a signal that the era of point solutions may be ending. Hospitals don't want to manage five separate AI overlays. They want integrated platforms. Expect more mergers like this across cardiology, oncology, and neurology imaging over the next 18 months.

Denmark's proposed wealth tax sparks startup exodus fears

PM Mette Frederiksen's Social Democrats have proposed a 0.5% annual wealth tax on fortunes exceeding DKK 25 million (roughly EUR 2.3 million), and the startup ecosystem is sounding the alarm. The critical detail: the tax would apply to unrealized gains on illiquid shares. That means founders get taxed on paper valuations they can't actually access.

The pushback has been swift and public. Vestas CEO Henrik Andersen and Maersk chairman Robert Maersk Uggla both stated they'd leave Denmark. Thea Messel of Unconventional Ventures called it potentially "damaging, particularly for the green transition." Sara Rywe of ByFounders shared a text from one of Denmark's "next unicorns": "We'll have to move to the UK if this goes through." Norway introduced a similar tax in 2022 and saw dozens of entrepreneurs relocate. Over half of Danish voters support the proposal, but the math may not work in Denmark's favor. Copenhagen is a bridge ride from Malmo. The friction of leaving is almost nonexistent.

BII backs five Danish deeptech spinouts in Venture House 8

The BioInnovation Institute (BII), a Novo Nordisk Foundation initiative, provided EUR 1.3 million in follow-on funding to five portfolio startups entering its Venture House 8 cohort: Synuca Therapeutics, Gefjon Pharma, MicroMiner, DARERL, and Diasense. Each company has now received EUR 1.8 million in total BII support. The cohort spans healthtech, pharma, agritech, and deeptech diagnostics. BII secured EUR 25 million in new Novo Nordisk Foundation funding last month, and its total commitment through 2035 stands at DKK 5.5 billion. Small checks at the right moment, paired with structured support and institutional credibility, remain the most underappreciated force in science-to-startup translation.

The BII investment sits in a broader trend of European deeptech programs gaining momentum. Paris-based Ventech closed a EUR 175 million fund for applied AI, Serena reached EUR 200 million for its Fund IV, and London's Evantic Capital launched a EUR 341 million debut vehicle targeting B2B AI. Patient capital for science-based startups is growing across the continent, and Denmark's institutional infrastructure gives it a genuine edge.

That's your Wednesday briefing. If you found this useful, forward it to someone building or investing in the Nordic tech ecosystem. We're back on Friday with more.